Literature DB >> 21726922

Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies.

Carla Mura1, Donatella Valenti, Costantino Floris, Roberta Sanna, Maria Antonietta De Luca, Anna Maria Fadda, Giuseppe Loy.   

Abstract

The aim of the present study was to develop a colon targeted delivery system for metronidazole using polymeric prodrug formulation. Two chitosan amide conjugates of metronidazole were prepared by using two different spacers to covalently link the drug to the amino group of the chitosan glucosamine units. Glutaric and succinic hemiesters of metronidazole were thus prepared and then coupled to chitosan to obtain metronidazole-glutaryl- and metronidazole-succinyl-chitosan conjugates. Polymeric prodrugs were characterized by solid state NMR method, namely carbon 13 cross polarization magic angle spinning ((13)C NMR CPMAS). Prodrug stability study was carried out in acid (pH = 1.2) and in alkaline (pH = 7.4) buffers in a thermostatic bath at 37 °C. Drug release from the two prodrugs was studied by incubating each of them with 10% w/v cecal and colonic content of rats. Obtained results showed that both prodrugs were adequately stable in acid environment, while the succinyl conjugate was more stable than the glutaryl one in alkaline buffer. Both the prodrugs released the drug in cecal and colonic content, showing that the two systems could serve as colon specific delivery systems of metronidazole.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726922     DOI: 10.1016/j.ejmech.2011.06.016

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Synthesis of a novel PEGylated colon-specific azo-based 4- aminosalicylic acid prodrug.

Authors:  Fatemeh Sadeghi; Atie Eidizade; Farinaz Saremnejad; Farzin Hadizadeh; Elham Khodaverdi; Abbas Akhgari
Journal:  Iran J Basic Med Sci       Date:  2020-06       Impact factor: 2.699

Review 2.  Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.

Authors:  Alexander A Nijevitch; Bulat Idrisov; Elsa N Akhmadeeva; David Y Graham
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

3.  Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery.

Authors:  Mihir K Raval; Riddhi V Ramani; Navin R Sheth
Journal:  Int J Pharm Investig       Date:  2013-10

Review 4.  Antimicrobial Properties of Chitosan and Chitosan Derivatives in the Treatment of Enteric Infections.

Authors:  Dazhong Yan; Yanzhen Li; Yinling Liu; Na Li; Xue Zhang; Chen Yan
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

5.  Synthesis and study the controlled release of etronidazole from the new PEG/NaY and PEG/MCM-41 nanocomposites.

Authors:  Mojgan Zendehdel; Giuseppe Cruciani; Forozan Sahra Kar; Abolfazl Barati
Journal:  J Environ Health Sci Eng       Date:  2014-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.